18,023 reports of this reaction
7.0% of all MYCOPHENOLATE MOFETIL HYDROCHLORIDE reports
#1 most reported adverse reaction
OFF LABEL USE is the #1 most commonly reported adverse reaction for MYCOPHENOLATE MOFETIL HYDROCHLORIDE, manufactured by Genentech, Inc.. There are 18,023 FDA adverse event reports linking MYCOPHENOLATE MOFETIL HYDROCHLORIDE to OFF LABEL USE. This represents approximately 7.0% of all 257,534 adverse event reports for this drug.
MYCOPHENOLATE MOFETIL HYDROCHLORIDE has an overall safety score of 92 out of 100. Patients taking MYCOPHENOLATE MOFETIL HYDROCHLORIDE who experience off label use should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
OFF LABEL USE is moderately reported among MYCOPHENOLATE MOFETIL HYDROCHLORIDE users, representing a notable but not dominant share of adverse events.
In addition to off label use, the following adverse reactions have been reported for MYCOPHENOLATE MOFETIL HYDROCHLORIDE:
The following drugs have also been linked to off label use in FDA adverse event reports:
OFF LABEL USE has been reported as an adverse event in 18,023 FDA reports for MYCOPHENOLATE MOFETIL HYDROCHLORIDE. This does not prove causation, but indicates an association observed in post-market surveillance data.
OFF LABEL USE accounts for approximately 7.0% of all adverse event reports for MYCOPHENOLATE MOFETIL HYDROCHLORIDE, making it one of the most commonly reported side effect.
If you experience off label use while taking MYCOPHENOLATE MOFETIL HYDROCHLORIDE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.